Diabetic retinopathy (DR) is a microvascular disease caused by poorly controlled blood
glucose, and it is a leading cause of vision loss in people with diabetes. In this review we …

Background Proliferative diabetic retinopathy (PDR) is an advanced complication of diabetic
retinopathy that can cause blindness. It consists of the presence of new vessels in the retina …

To investigate the mechanism of vascular endothelial growth factor (VEGF) and brain-
derived neurotrophic factor (BDNF) in Müller cell (MC) viability and neuroprotection in …

Topic To evaluate the efficacy and safety of anti-vascular endothelial growth factor (VEGF)
and panretinal photocoagulation (PRP) for the treatment of proliferative diabetic retinopathy …

Background We determined the cost-effectiveness of the anti-vascular endothelial growth
factor (VEGF) intravitreal injection versus panretinal photocoagulation (PRP) for patients …

Objective To compare the efficacy and safety of panretinal photocoagulation (PRP)
combined with intravitreal anti-vascular endothelial growth factor (anti-VEGF) against PRP …

Diabetic retinopathy has a high probability of causing visual impairment or blindness
throughout the disease progression and is characterized by the growth of new blood vessels …

Exosomes are nanosized vesicles that have been reported as cargo-delivering vehicles
between cells. Müller cells play a crucial role in the pathogenesis of diabetic retinopathy …

Somatostatin, a naturally produced neuroprotective peptide, depresses excitatory
neurotransmission and exerts anti-proliferative and anti-inflammatory effects on the retina. In …

Purpose To determine the rate of loss to follow up (LTFU) in patients with proliferative
diabetic retinopathy (PDR) treated with anti-VEGF therapy and/or panretinal …